+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

An open-label pilot study of methylphenidate in the treatment of cocaine-dependent patients with attention deficit hyperactivity disorder



An open-label pilot study of methylphenidate in the treatment of cocaine-dependent patients with attention deficit hyperactivity disorder



Drug & Alcohol Dependence 60(Suppl 1): S208-S209, 1 December




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034395106

Download citation: RISBibTeXText


Related references

An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. Journal of Addictive Diseases 23(1): 77-92, 2004

Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial. Clinical Neuropharmacology 32(4): 179-182, 2009

Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. Journal of Clinical Psychiatry 59(6): 300-305, 1998

The open-label treatment of attention-deficit/hyperactivity disorder in 4- and 5-year-old children with beaded methylphenidate. Journal of Child and Adolescent Psychopharmacology 19(2): 147-153, 2009

An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 25(7): 566-573, 2016

Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder. Journal of Child and Adolescent Psychopharmacology 28(5): 298-305, 2018

Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial. International Clinical Psychopharmacology 23(4): 228-231, 2008

Methylphenidate treatment for attention-deficit/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: an open-label study. Journal of Clinical Psychiatry 64(10): 1163-1169, 2003

Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results. Pediatrics 120(1): E120-E128, 2007

Prospective, naturalistic study of open-label OROS methylphenidate treatment in Chinese school-aged children with attention-deficit/hyperactivity disorder. Chinese Medical Journal 124(20): 3269-3274, 2012

An open-label pilot study of homeopathic treatment of attention deficit hyperactivity disorder in children and youth. Forschende Komplementarmedizin 21(5): 302-309, 2015

Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study. Journal of Child and Adolescent Psychopharmacology 2018, 2018

Effects of methylphenidate on leptin and appetite in children with attention-deficit hyperactivity disorder: an open label trial. Methods and Findings in Experimental and Clinical Pharmacology 29(1): 47-52, 2007

Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension. British Journal of Psychiatry 200(1): 68-73, 2012

Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 19(2): 155-166, 2009